MeCP2 R106 was identified as dimethylated in our mass spectrometry analysis and is commonly mutated in Rett syndrome patients to tryptophan (W) and glutamine (Q), in very few cases also to glycine (G) and leucine (L). Here, MECP2 is linked to atypical Rett syndrome.